Clearside Short Long Term Debt Total from 2010 to 2024
CLSD Stock | USD 1.36 0.01 0.74% |
Short and Long Term Debt Total | First Reported 2015-09-30 | Previous Quarter 43 M | Current Value 45.3 M | Quarterly Volatility 9.9 M |
Check Clearside Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearside main balance sheet or income statement drivers, such as Depreciation And Amortization of 63.6 K, Interest Expense of 9.8 M or Other Operating Expenses of 35.5 M, as well as many exotic indicators such as Price To Sales Ratio of 8.35, Dividend Yield of 0.0 or Days Sales Outstanding of 8.24. Clearside financial statements analysis is a perfect complement when working with Clearside Biomedical Valuation or Volatility modules.
Clearside | Short Long Term Debt Total |
Latest Clearside Biomedical's Short Long Term Debt Total Growth Pattern
Below is the plot of the Short Long Term Debt Total of Clearside Biomedical over the last few years. It is Clearside Biomedical's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearside Biomedical's overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
Timeline |
Clearside Short Long Term Debt Total Regression Statistics
Arithmetic Mean | 9,139,670 | |
Geometric Mean | 2,661,817 | |
Coefficient Of Variation | 159.49 | |
Mean Deviation | 9,427,739 | |
Median | 5,976,000 | |
Standard Deviation | 14,576,662 | |
Sample Variance | 212.5T | |
Range | 44.9M | |
R-Value | 0.62 | |
Mean Square Error | 140T | |
R-Squared | 0.39 | |
Significance | 0.01 | |
Slope | 2,030,569 | |
Total Sum of Squares | 2974.7T |
Clearside Short Long Term Debt Total History
About Clearside Biomedical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Clearside Biomedical income statement, its balance sheet, and the statement of cash flows. Clearside Biomedical investors use historical funamental indicators, such as Clearside Biomedical's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Clearside Biomedical investors may use each financial statement separately, they are all related. The changes in Clearside Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Clearside Biomedical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Clearside Biomedical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Clearside Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Short and Long Term Debt Total | 43 M | 45.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce |
Check out the analysis of Clearside Biomedical Correlation against competitors. For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Clearside Stock analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Clearside Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.132 | Quarterly Revenue Growth 56.5 | Return On Assets (0.38) | Return On Equity (13.10) |
The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.